Radiofrequency Ablation of Recurrent Metastatic Papillary Thyroid Cancer to a Lymph Node

Ahmad, Shahzad; Orozco, Ian James; Raashid, Sheheryar; Hamid, Zainab A.; Aljammal, Jules

doi:10.1016/j.aace.2022.07.003

AACE Clinical Case Reports

2022

DOI: 10.1016/j.aace.2022.07.003

|View full text |Cite

Radiofrequency Ablation of Recurrent Metastatic Papillary Thyroid Cancer to a Lymph Node

Shahzad Ahmad¹,

Ian James Orozco²,

Sheheryar Raashid³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2023

Publication Types

Select...

Article3

Relationship

Self Cite1

Independent2

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 4 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the field of Thyroid Disease, authors shared an interesting video describing radiofrequency ablation of recurrent metastatic papillary thyroid cancer in a lymph node. 11 A visual vignette of rapidly enlarging neck mass as a common presentation of anaplastic thyroid cancer was also described. 12 …”

mentioning

confidence: 99%

Editorial for November/December Issue of AACE Clinical Case Reports

Jasim¹

2022

AACE Clinical Case Reports

View full text Add to dashboard Cite

mentioning

confidence: 99%

Editorial for November/December Issue of AACE Clinical Case Reports

Jasim¹

2022

AACE Clinical Case Reports

View full text Add to dashboard Cite

Recurrent Papillary Thyroid Carcinoma of Central Compartment Node Treated With Radiofrequency Ablation

Ahmad,

Asad,

Khan

et al. 2023

VideoEndocrinology™

View full text Add to dashboard Cite

Radiofrequency Ablation of Cervical Thyroid Cancer Metastases—Experience of Endocrinology Practices in the United States

Ahmad¹,

Aljammal²,

Orozco³

et al. 2023

Journal of the Endocrine Society

Self Cite

View full text Add to dashboard Cite

Context Radiofrequency ablation (RFA) is used in the United States to treat benign thyroid nodules; however, experience with treating cervical recurrence/persistence of papillary thyroid cancer (PTC) is limited. Objective To evaluate the efficacy RFA for the treatment of cervical recurrence/persistence of PTC in the United States. Methods This is a retrospective, multicenter study of 8 patients who underwent RFA of 11 cervical metastatic PTC lesions between July 2020 and December 2021. The volume reduction (VR) of the lesions, thyroglobulin (Tg) levels and complications following RFA were assessed. Energy applied per unit volume (E/V) during RFA was also determined. Results Nine out of 11 (81.8%) lesions had initial volume under 0.5 ml and showed a complete (n = 8) or near complete (n = 1) response. The two lesions with initial volume over 1.1 ml had a partial response; one of which had regrowth. There was a median VR of 100% (range: 56.3–100%) after a median follow-up period of 453 days (range: 162–570 days), with corresponding decline in Tg levels from a median of 0.7 ng/ml (range: 0–15.2 ng/ml) to a median of 0.3 ng/ml (range: 0–1.3 ng/ml). All patients with an E/V of at least 4483 J/ml or higher had a complete or near complete response. There were no complications. Conclusion RFA performed in an endocrinology practice is an efficacious treatment option for selected patients with cervical metastases of PTC, particularly those who cannot or do not want to undergo further surgery.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Radiofrequency Ablation of Recurrent Metastatic Papillary Thyroid Cancer to a Lymph Node

Cited by 3 publications

References 4 publications

Editorial for November/December Issue of AACE Clinical Case Reports

Editorial for November/December Issue of AACE Clinical Case Reports

Recurrent Papillary Thyroid Carcinoma of Central Compartment Node Treated With Radiofrequency Ablation

Radiofrequency Ablation of Cervical Thyroid Cancer Metastases—Experience of Endocrinology Practices in the United States

Contact Info

Product

Resources

About